,140 Studies have demonstrated that DEXs derived from tumor-pulsed DCs can induce robust antigen-specific CD8+ T cell activation and the generation of memory T cells capable of mounting long-term immune responses against tumors. This evidence concerns the gene CD8A and neoplasm.